BAJAJHCARE

Bajaj Healthcare Share Price

₹372.50 +5.8 (1.58%)

05 Nov, 2024 17:29

SIP TrendupStart SIP in BAJAJHCARE

Start SIP

Performance

  • Low
  • ₹365
  • High
  • ₹378
  • 52 Week Low
  • ₹263
  • 52 Week High
  • ₹429
  • Open Price₹368
  • Previous Close₹367
  • Volume109,430

Investment Returns

  • Over 1 Month + 0.98%
  • Over 3 Month + 0.42%
  • Over 6 Month + 15.67%
  • Over 1 Year -9.85%
SIP Lightning

Smart Investing Starts Here Start SIP with Bajaj Healthcare for Steady Growth!

Bajaj Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -41.4
  • PEG Ratio
  • 0.6
  • Market Cap Cr
  • 1,177
  • P/B Ratio
  • 4.2
  • Average True Range
  • 13.96
  • EPS
  • -14.3
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -5.54
  • RSI
  • 48.12
  • MFI
  • 46.27

Bajaj Healthcare Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations132.25133.90108.57101.21129.74
Total Income From Operations132.25133.90108.57101.21129.74
P/L Before Interest, Excpt. Items & Tax18.6315.1912.9813.5115.66
P/L Before Exceptional Items & Tax10.189.186.335.246.90
P/L After Tax from Ordinary Activities8.03-32.005.525.127.03
Net Profit/Loss For the Period7.13-29.92-2.20-3.46-48.21
IndicatorMar 24Mar 23
Revenue From Operations [Gross]472.93673.29
Revenue From Operations [Net]472.93673.29
Total Operating Revenues473.42673.29
Total Revenue482.10674.89
Total Expenses454.45616.67
Profit/Loss Before Tax-16.6858.22
Profit/Loss For The Period-83.7943.02
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity92.29-22.32
Net Cash Used In Investing Activity-11.24-93.43
Net Cash Used in Finance Activity-96.60131.50
Net Inc/Dec In Cash And Equivalent-15.5515.75
Cash And Equivalent End Of Year2.1717.72
IndicatorMar 24Mar 23
Total Share Capital13.8013.80
Total Non-Current Liabilities45.2997.71
Total Current Liabilities441.48436.06
Total Capital And Liabilities765.13901.46
Total Non-Current Assets285.08391.72
Total Current Assets480.05509.74
Total Assets765.13901.46
Indicator20242023
EBIT Margin (%)12.1112.04
Return On Capital Employed (%)17.7117.42
Return On Equity (%)-30.1011.70
Long Term Debt To Equity (%)13.8525.47
Book Value/Share (INR)100.86133.23
Indicator20242023
EBIT Margin (%)12.1112.04
Return On Capital Employed (%)17.7117.42
Return On Equity (%)-30.1011.70
Long Term Debt To Equity (%)13.8525.47
Book Value/Share (INR)100.86133.23

Bajaj Healthcare Technicals

EMA & SMA

Current Price
₹372.50
+ 5.8 (1.58%)
pointer
  • stock-down_img
  • Bullish Moving Average 13
  • stock-up_img
  • Bearish Moving Average 3
  • 20 Day
  • ₹367.51
  • 50 Day
  • ₹372.66
  • 100 Day
  • ₹367.51
  • 200 Day
  • ₹360.23

Resistance and Support

365.97 Pivot Speed
  • R3 386.43
  • R2 379.37
  • R1 373.03
  • S1 359.63
  • S2 352.57
  • S3 346.23

Is Bajaj Healthcare Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Bajaj Healthcare manufactures and supplies active pharmaceutical ingredients (APIs), intermediates, and finished formulations. Serving the pharmaceutical, nutraceutical, and healthcare industries, it provides high-quality products to both domestic and international markets. Bajaj Healthcare has an operating revenue of Rs. 475.93 Cr. on a trailing 12-month basis. An annual revenue de-growth of -29% needs improvement, Pre-tax margin of -4% needs improvement, ROE of -30% is poor and needs improvement. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 31 which is a POOR score indicating inconsistency in earnings, a RS Rating of 41 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 35 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Bajaj Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-09-19 Others Inter alia, to consider and approve the Allotment of Equity shares and Warrants. per share(5%)Special Dividend
2024-08-14 Quarterly Results & ESOP
2024-07-10 Preferential issue of shares
2024-05-24 Audited Results & Final Dividend
2024-02-09 Quarterly Results
Date Purpose Remarks
2021-09-29 FINAL Rs.0.50 per share(5%)Final Dividend
2021-09-29 SPECIAL Rs.0.50 per share(5%)Special Dividend
Date Purpose Remarks
2021-09-29 Split Rs.0.00 split from Rs. 10/- to Rs. 5/-.

Bajaj Healthcare F&O

Bajaj Healthcare Shareholding Pattern

59.19%
1.31%
1.07%
25.51%
12.92%
  • NSE Symbol
  • BAJAJHCARE
  • BSE Symbol
  • 539872
  • Chairman & Managing Director
  • Mr. Sajankumar R Bajaj
  • ISIN
  • INE411U01027

Bajaj Healthcare FAQs

Bajaj Healthcare share price is ₹372 As on 05 November, 2024 | 17:15

The Market Cap of Bajaj Healthcare is ₹1176.5 Cr As on 05 November, 2024 | 17:15

The P/E ratio of Bajaj Healthcare is -41.4 As on 05 November, 2024 | 17:15

The PB ratio of Bajaj Healthcare is 4.2 As on 05 November, 2024 | 17:15

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form